ICU Sedation Clinical Trial
Official title:
Phase 3, Multi-center, Single-arm, Open-label Study Evaluating The Efficacy, Safety, And Pharmacokinetics Of Da-9501 (Dexmedetomidine Hydrochloride) In Pediatric Subjects In The Intensive Care Unit
To evaluate the efficacy, safety, and pharmacokinetics of dexmedetomidine given as continuous IV infusion in pediatric subjects [≥ 45 weeks CGA (corrected gestational age) to <17 years old] requiring sedation under intensive care unit
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03813277 -
Safety, Tolerability and Efficacy of DEXDOR in Pediatric Patients in ICU
|
Phase 4 |